{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:04:49Z","timestamp":1791165889807,"version":"4.1.0"},"publisher-location":"Cham","reference-count":167,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032121653","type":"print"},{"value":"9783032121660","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-12166-0_17","type":"book-chapter","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:17:04Z","timestamp":1783768624000},"page":"479-501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mitochondrial Energy Metabolism in Cancer, Immunoregulation and Antitumour Response"],"prefix":"10.1007","author":[{"given":"Jo\u00e3o S.","family":"Patr\u00edcio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo A.","family":"Gameiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"e56788","DOI":"10.7759\/cureus.56788","volume":"16","author":"FI Abaleka","year":"2024","unstructured":"Abaleka FI, Bedanie G, Olavarria Bernal D et al (2024) Type B lactic acidosis: a very rare but fatal complication of gastrointestinal solid tumor. Cureus 16:e56788. https:\/\/doi.org\/10.7759\/cureus.56788","journal-title":"Cureus"},{"key":"17_CR2","unstructured":"Abbas AK, Lichtman AH, Pillai S, Baker DL (2022) Cellular and molecular immunology. Elsevier, Philadelphia, Pennsylvania"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.21037\/atm.2018.12.34","volume":"6","author":"M Agana","year":"2018","unstructured":"Agana M, Frueh J, Kamboj M et al (2018) Common metabolic disorder (inborn errors of metabolism) concerns in primary care practice. Ann Transl Med 6:469\u2013469. https:\/\/doi.org\/10.21037\/atm.2018.12.34","journal-title":"Ann Transl Med"},{"key":"17_CR4","doi-asserted-by":"crossref","unstructured":"Ahn M, Ali A, Seo JH (2024) Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy. Front Immunol 15:1\u20138","DOI":"10.3389\/fimmu.2024.1453886"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mito.2021.12.001","volume":"62","author":"H Akbari","year":"2022","unstructured":"Akbari H, Taghizadeh-Hesary F, Bahadori M (2022) Mitochondria determine response to anti-programmed cell death protein-1 (anti-PD-1) immunotherapy: an evidence-based hypothesis. Mitochondrion 62:151\u2013158. https:\/\/doi.org\/10.1016\/j.mito.2021.12.001","journal-title":"Mitochondrion"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2006.03.005","volume":"450","author":"NL Alderson","year":"2006","unstructured":"Alderson NL, Wang Y, Blatnik M et al (2006) S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate. Arch Biochem Biophys 450:1\u20138. https:\/\/doi.org\/10.1016\/j.abb.2006.03.005","journal-title":"Arch Biochem Biophys"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"eabj3510","DOI":"10.1126\/science.abj3510","volume":"378","author":"M Al-Habsi","year":"2025","unstructured":"Al-Habsi M, Chamoto K, Matsumoto K et al (2025) Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice. Science (1979) 378:eabj3510. https:\/\/doi.org\/10.1126\/science.abj3510","journal-title":"Science (1979)"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrc.2016.131","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman BJ, Stine ZE, Dang CV (2016) From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer 16:773. https:\/\/doi.org\/10.1038\/nrc.2016.131","journal-title":"Nat Rev Cancer"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner EN, Rathmell JC (2023) Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41:421\u2013433. https:\/\/doi.org\/10.1016\/j.ccell.2023.01.009","journal-title":"Cancer Cell"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS (2018) Oxidative phosphorylation as an emerging target in cancer therapy. Clin Cancer Res 24:2482\u20132490. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3070","journal-title":"Clin Cancer Res"},{"key":"17_CR11","doi-asserted-by":"crossref","unstructured":"Bai R, Cui J (2023) Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria. Cancer Lett 564:1\u201310","DOI":"10.1016\/j.canlet.2023.216223"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/emboj.2011.25","volume":"30","author":"F Baixauli","year":"2011","unstructured":"Baixauli F, Mart\u00edn-C\u00f3freces NB, Morlino G et al (2011) The mitochondrial fission factor dynamin-related protein 1 modulates T-cell receptor signalling at the immune synapse. EMBO J 30:1238\u20131250. https:\/\/doi.org\/10.1038\/emboj.2011.25","journal-title":"EMBO J"},{"key":"17_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03505-1","volume":"12","author":"X Bao","year":"2021","unstructured":"Bao X, Zhang J, Huang G et al (2021) The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. Cell Death Dis 12: 215. https:\/\/doi.org\/10.1038\/s41419-021-03505-1","journal-title":"Cell Death Dis"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"1101433","DOI":"10.3389\/fimmu.2023.1101433","volume":"14","author":"L Barbieri","year":"2023","unstructured":"Barbieri L, Veli\u00e7a P, Gameiro PA et al (2023) Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells. Front Immunol 14:1101433. https:\/\/doi.org\/10.3389\/fimmu.2023.1101433","journal-title":"Front Immunol"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.canlet.2016.11.040","volume":"388","author":"A Bastian","year":"2017","unstructured":"Bastian A, Matsuzaki S, Humphries KM et al (2017) AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1\u03b1 stabilization. Cancer Lett\u2009388:149\u2013157.\u2009https:\/\/doi.org\/10.1016\/j.canlet.2016.11.040","journal-title":"Cancer Lett"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"18406","DOI":"10.1074\/jbc.REV120.011202","volume":"295","author":"U Basu","year":"2020","unstructured":"Basu U, Bostwick AM, Das K et al (2020) Structure, mechanism, and regulation of mitochondrial DNA transcription initiation. J Biol Chem 295:18406\u201318425. https:\/\/doi.org\/10.1074\/jbc.REV120.011202","journal-title":"J Biol Chem"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","volume":"45","author":"B Bengsch","year":"2016","unstructured":"Bengsch B, Johnson AL, Kurachi M et al (2016) Bioenergeticinsufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion. Immunity 45:358\u2013373. https:\/\/doi.org\/10.1016\/j.immuni.2016.07.008","journal-title":"Immunity"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41586-024-07812-3","volume":"633","author":"D Bezwada","year":"2024","unstructured":"Bezwada D, Perelli L, Lesner NP et al (2024) Mitochondrial complex I promotes kidney cancer metastasis. Nature 633:923\u2013931. https:\/\/doi.org\/10.1038\/s41586-024-07812-3","journal-title":"Nature"},{"key":"17_CR19","doi-asserted-by":"publisher","unstructured":"Bisbach CM, Hass DT, Robbings BM et al (2020) Succinate can shuttle reducing power from the hypoxic retina to the O2-rich pigment epithelium. Cell Rep 31. https:\/\/doi.org\/10.1016\/j.celrep.2020.107606","DOI":"10.1016\/j.celrep.2020.107606"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/1078-0432.CCR-20-3913","volume":"27","author":"DF Boreel","year":"2021","unstructured":"Boreel DF, Span PN, Heskamp S et al (2021) Targeting oxidative phosphorylation to increase the efficacy of radio- and immune-combination therapy. Clin Cancer Res 27:2970\u20132978. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3913","journal-title":"Clin Cancer Res"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/nar\/gks1130","volume":"41","author":"LS Borowski","year":"2013","unstructured":"Borowski LS, Dziembowski A, Hejnowicz MS et al (2013) Human mitochondrial RNA decay mediated by PNPase\u2013hSuv3 complex takes place in distinct foci. Nucleic Acids Res 41:1223\u20131240. https:\/\/doi.org\/10.1093\/nar\/gks1130","journal-title":"Nucleic Acids Res"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1172\/JCI117261","volume":"93","author":"T Bourgeron","year":"1994","unstructured":"Bourgeron T, Chretien D, Poggi-Bach J et al (1994) Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. J Clin Invest 93:2514\u20132518. https:\/\/doi.org\/10.1172\/JCI117261","journal-title":"J Clin Invest"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE et al (2016) LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab 24:657\u2013671. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.011","journal-title":"Cell Metab"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","volume":"166","author":"MD Buck","year":"2016","unstructured":"Buck MD, O\u2019Sullivan D, Klein Geltink RI et al (2016) Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166:63\u201376. https:\/\/doi.org\/10.1016\/j.cell.2016.05.035","journal-title":"Cell"},{"key":"17_CR25","doi-asserted-by":"publisher","unstructured":"Casey AM, Ryan DG, Prag HA et al (2025) Pro-inflammatory macrophages produce mitochondria-derived superoxide by reverse electron transport at complex I that regulates IL-1\u03b2 release during NLRP3 inflammasome activation. Nat Metab https:\/\/doi.org\/10.1038\/s42255-025-01224-x","DOI":"10.1038\/s42255-025-01224-x"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1002\/eji.200838289","volume":"38","author":"CM Cham","year":"2008","unstructured":"Cham CM, Driessens G, O\u2019Keefe JP, Gajewski TF (2008) Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells. Eur J Immunol 38:2438\u20132450. https:\/\/doi.org\/10.1002\/eji.200838289","journal-title":"Eur J Immunol"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"E761","DOI":"10.1073\/PNAS.1620433114","volume":"114","author":"K Chamoto","year":"2017","unstructured":"Chamoto K, Chowdhury PS, Kumar A et al (2017) Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. Proc Natl Acad Sci USA 114:E761\u2013E770. https:\/\/doi.org\/10.1073\/PNAS.1620433114","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"C-H Chang","year":"2015","unstructured":"Chang C-H, Qiu J, O\u2019Sullivan D et al (2015) Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162:1229\u20131241. https:\/\/doi.org\/10.1016\/j.cell.2015.08.016","journal-title":"Cell"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2021.12.012","volume":"55","author":"NM Chapman","year":"2022","unstructured":"Chapman NM, Chi H (2022) Metabolic adaptation of lymphocytes in immunity and disease. Immunity 55:14\u201330. https:\/\/doi.org\/10.1016\/j.immuni.2021.12.012","journal-title":"Immunity"},{"key":"17_CR30","doi-asserted-by":"publisher","unstructured":"Chavda V, Lu B (2023) Reverse electron transport at mitochondrial complex I in ischemic stroke, aging, and age-related diseases. Antioxidants (Basel) 12. https:\/\/doi.org\/10.3390\/antiox12040895","DOI":"10.3390\/antiox12040895"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"e000289","DOI":"10.1136\/jitc-2019-000289","volume":"8","author":"D Chen","year":"2020","unstructured":"Chen D, Barsoumian HB, Fischer G et al (2020) Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity. J Immunother Cancer 8:e000289. https:\/\/doi.org\/10.1136\/jitc-2019-000289","journal-title":"J Immunother Cancer"},{"key":"17_CR32","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.cmet.2018.03.002","volume":"27","author":"Q Chen","year":"2018","unstructured":"Chen Q, Kirk K, Shurubor YI et al (2018) Rewiring of glutamine metabolism is a bioenergetic adaptation of human cells with mitochondrial DNA mutations. Cell Metab 27:1007\u20131025.e5. https:\/\/doi.org\/10.1016\/j.cmet.2018.03.002","journal-title":"Cell Metab"},{"key":"17_CR33","doi-asserted-by":"publisher","unstructured":"Chen S, Liao Z, Xu P (2023) Mitochondrial control of innate immune responses. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1166214","DOI":"10.3389\/fimmu.2023.1166214"},{"key":"17_CR34","doi-asserted-by":"crossref","unstructured":"Chen S, Zhang Z, Zheng X et al (2021) Response Efficacy of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis. Front Oncol 11","DOI":"10.3389\/fonc.2021.562315"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"e001372","DOI":"10.1136\/jitc-2020-001372","volume":"8","author":"AN Cheng","year":"2020","unstructured":"Cheng AN, Cheng L-C, Kuo C-L et al (2020) Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles. J Immunother Cancer 8:e001372. https:\/\/doi.org\/10.1136\/jitc-2020-001372","journal-title":"J Immunother Cancer"},{"key":"17_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani ET, Pell VR, Gaude E et al (2014) Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515:431\u2013435. https:\/\/doi.org\/10.1038\/nature13909","journal-title":"Nature"},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-18-0095","volume":"6","author":"PS Chowdhury","year":"2018","unstructured":"Chowdhury PS, Chamoto K, Kumar A, Honjo T (2018) PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8+ T cells and facilitates anti-PD-1 therapy. Cancer Immunol Res 6:1375\u20131387. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0095","journal-title":"Cancer Immunol Res"},{"key":"17_CR38","doi-asserted-by":"crossref","unstructured":"Cong J (2020) Metabolism of natural killer cells and other innate lymphoid cells. Front Immunol 11","DOI":"10.3389\/fimmu.2020.01989"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/epirev\/mxx007","volume":"39","author":"P Cormie","year":"2017","unstructured":"Cormie P, Zopf EM, Zhang X, Schmitz KH (2017) The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiol Rev 39:71\u201392. https:\/\/doi.org\/10.1093\/epirev\/mxx007","journal-title":"Epidemiol Rev"},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1042\/BST20120351","volume":"41","author":"M Dandapani","year":"2013","unstructured":"Dandapani M, Hardie DG (2013) AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells. Biochem Soc Trans 41:687\u2013693. https:\/\/doi.org\/10.1042\/BST20120351","journal-title":"Biochem Soc Trans"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nature09132","volume":"465","author":"L Dang","year":"2010","unstructured":"Dang L, White DW, Gross S et al (2010) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 465:966. https:\/\/doi.org\/10.1038\/nature09132","journal-title":"Nature"},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","volume":"9","author":"KG de la Cruz-L\u00f3pez","year":"2019","unstructured":"de la Cruz-L\u00f3pez KG, Castro-Mu\u00f1oz LJ, Reyes-Hern\u00e1ndez DO et al (2019) Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front Oncol 9:1143. https:\/\/doi.org\/10.3389\/fonc.2019.01143","journal-title":"Front Oncol"},{"key":"17_CR43","doi-asserted-by":"crossref","unstructured":"De Vivo DC, DiMauro S (2017) Mitochondrial diseases. In: Swaiman\u2019s Pediatric Neurology, Sixth Ed. Elsevier, Edinburgh, United Kingdom pp 334\u2013346","DOI":"10.1016\/B978-0-323-37101-8.00042-4"},{"key":"17_CR44","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2:e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200","journal-title":"Sci Adv"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.aax0860","volume":"368","author":"G Desd\u00edn-Mic\u00f3","year":"2020","unstructured":"Desd\u00edn-Mic\u00f3 G, Soto-Heredero G, Aranda JF et al (2020) T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science (1979) 368:1371\u20131376.\u2009https:\/\/doi.org\/10.1126\/science.aax0860","journal-title":"Science (1979)"},{"key":"17_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41586-018-0363-0","volume":"560","author":"A Dhir","year":"2018","unstructured":"Dhir A, Dhir S, Borowski LS et al (2018) Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 560:238\u2013242. https:\/\/doi.org\/10.1038\/s41586-018-0363-0","journal-title":"Nature"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"Doherty JR, Cleveland JL (2013) Targeting lactate metabolism for cancer therapeutics. J Clin Invest 123:3685\u20133692. https:\/\/doi.org\/10.1172\/JCI69741","journal-title":"J Clin Invest"},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1073\/pnas.1417636112","volume":"112","author":"S Eikawa","year":"2015","unstructured":"Eikawa S, Nishida M, Mizukami S et al (2015) Immune-mediated antitumor effect by type 2 diabetes drug, metformin. Proc Natl Acad Sci USA 112:1809\u20131814. https:\/\/doi.org\/10.1073\/pnas.1417636112","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","volume":"17","author":"B Faubert","year":"2013","unstructured":"Faubert B, Boily G, Izreig S et al (2013) AMPK is a negative regulator of the warburg effect and suppresses tumor growth in vivo. Cell Metab 17:113\u2013124. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.001","journal-title":"Cell Metab"},{"key":"17_CR50","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","volume":"171","author":"B Faubert","year":"2017","unstructured":"Faubert B, Li KY, Cai L et al (2017) Lactate metabolism in human lung tumors. Cell 171:358\u2013371.e9. https:\/\/doi.org\/10.1016\/j.cell.2017.09.019","journal-title":"Cell"},{"key":"17_CR51","doi-asserted-by":"publisher","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science (1979) 368. https:\/\/doi.org\/10.1126\/science.aaw5473","DOI":"10.1126\/science.aaw5473"},{"key":"17_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3236","volume":"4","author":"S-M Fendt","year":"2013","unstructured":"Fendt S-M, Bell EL, Keibler MA et al (2013a) Reductive glutamine metabolism is a function of the \u03b1-ketoglutarate to citrate ratio in cells. Nat Commun 4: 2236. https:\/\/doi.org\/10.1038\/ncomms3236","journal-title":"Nat Commun"},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/0008-5472.CAN-13-0080","volume":"73","author":"S-M Fendt","year":"2013","unstructured":"Fendt S-M, Bell EL, Keibler MA et al (2013b) Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Res 73:4429\u20134438. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0080","journal-title":"Cancer Res"},{"key":"17_CR54","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1002\/cam4.1820","volume":"7","author":"Y Feng","year":"2018","unstructured":"Feng Y, Xiong Y, Qiao T et al (2018) Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy. Cancer Med 7:6124\u20136136. https:\/\/doi.org\/10.1002\/cam4.1820","journal-title":"Cancer Med"},{"key":"17_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cmet.2013.02.002","volume":"17","author":"PA Gameiro","year":"2013","unstructured":"Gameiro PA, Yang J, Metelo AM et al (2013) In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. Cell Metab 17:372\u2013385. https:\/\/doi.org\/10.1016\/j.cmet.2013.02.002","journal-title":"Cell Metab"},{"key":"17_CR56","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","volume":"20","author":"J Garcia-Bermudez","year":"2018","unstructured":"Garcia-Bermudez J, Baudrier L, La K et al (2018) Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat Cell Biol 20:775\u2013781. https:\/\/doi.org\/10.1038\/s41556-018-0118-z","journal-title":"Nat Cell Biol"},{"key":"17_CR57","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 4:891\u2013899. https:\/\/doi.org\/10.1038\/nrc1478","journal-title":"Nat Rev Cancer"},{"key":"17_CR58","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1126\/science.1151710","volume":"318","author":"T Gerken","year":"2007","unstructured":"Gerken T, Girard CA, Tung Y-CL et al (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318:1469\u20131472. https:\/\/doi.org\/10.1126\/science.1151710","journal-title":"Science"},{"key":"17_CR59","doi-asserted-by":"publisher","unstructured":"Goncalves RLS, Wang ZB, Riveros JK et al (2025) CoQ imbalance drives reverse electron transport to disrupt liver metabolism. Nature. https:\/\/doi.org\/10.1038\/s41586-025-09072-1","DOI":"10.1038\/s41586-025-09072-1"},{"key":"17_CR60","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.semcancer.2022.02.002","volume":"86","author":"J Greene","year":"2022","unstructured":"Greene J, Segaran A, Lord S (2022) Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications. Semin Cancer Biol 86:851\u2013859. https:\/\/doi.org\/10.1016\/j.semcancer.2022.02.002","journal-title":"Semin Cancer Biol"},{"key":"17_CR61","doi-asserted-by":"publisher","unstructured":"Gut P, Matilainen S, Meyer JG et al (2020) SUCLA2 mutations cause global protein succinylation contributing to the pathomechanism of a hereditary mitochondrial disease. Nat Commun 11. https:\/\/doi.org\/10.1038\/s41467-020-19743-4","DOI":"10.1038\/s41467-020-19743-4"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3389\/fonc.2019.01201","volume":"9","author":"S Han","year":"2019","unstructured":"Han S, Wei R, Zhang X et al (2019) CPT1A\/2-mediated FAO enhancement\u2014a metabolic target in radioresistant breast cancer. Front Oncol 9:1201. https:\/\/doi.org\/10.3389\/fonc.2019.01201","journal-title":"Front Oncol"},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.3390\/CANCERS14143331","volume":"14","author":"MN Hasan","year":"2022","unstructured":"Hasan MN, Capuk O, Patel SM, Sun D (2022) The role of metabolic plasticity of tumor-associated macrophages in shaping the tumor microenvironment immunity. Cancers 14:3331. https:\/\/doi.org\/10.3390\/CANCERS14143331","journal-title":"Cancers"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"eadp3475","DOI":"10.1126\/sciimmunol.adp3475","volume":"9","author":"DR Heintzman","year":"2024","unstructured":"Heintzman DR, Sinard RC, Fisher EL et al (2024) Subset-specific mitochondrial stress and DNA damage shape T cell responses to fever and inflammation. Sci Immunol 9:eadp3475. https:\/\/doi.org\/10.1126\/sciimmunol.adp3475","journal-title":"Sci Immunol"},{"key":"17_CR65","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1074\/mcp.R114.046664","volume":"14","author":"MD Hirschey","year":"2015","unstructured":"Hirschey MD, Zhao Y (2015) Metabolic regulation by lysine malonylation, succinylation, and glutarylation. Mol Cell Proteomics 14:2308\u20132315. https:\/\/doi.org\/10.1074\/mcp.R114.046664","journal-title":"Mol Cell Proteomics"},{"key":"17_CR66","doi-asserted-by":"publisher","unstructured":"Hu M, Zhou M, Bao X et al (2021) ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation. J Clin Invest 131. https:\/\/doi.org\/10.1172\/JCI139333","DOI":"10.1172\/JCI139333"},{"key":"17_CR67","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","volume":"150","author":"R Huang","year":"2024","unstructured":"Huang R, Kang T, Chen S (2024) The role of tumor-associated macrophages in tumor immune evasion. J Cancer Res Clin Oncol 150:238. https:\/\/doi.org\/10.1007\/s00432-024-05777-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"17_CR68","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nri1245","volume":"3","author":"JB Huppa","year":"2003","unstructured":"Huppa JB, Davis MM (2003) T-cell-antigen recognition and the immunological synapse. Nat Rev Immunol 3:973\u2013983. https:\/\/doi.org\/10.1038\/nri1245","journal-title":"Nat Rev Immunol"},{"key":"17_CR69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","volume":"8","author":"JS Isaacs","year":"2005","unstructured":"Isaacs JS, Yun JJ, Mole DR et al (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143\u2013153. https:\/\/doi.org\/10.1016\/j.ccr.2005.06.017","journal-title":"Cancer Cell"},{"key":"17_CR70","doi-asserted-by":"publisher","first-page":"2008065","DOI":"10.1002\/adma.202008065","volume":"33","author":"H Jiang","year":"2021","unstructured":"Jiang H, Guo Y, Wei C et al (2021) Nanocatalytic innate immunity activation by mitochondrial DNA oxidative damage for tumor-specific therapy. Adv Mater\u200933:2008065.\u2009https:\/\/doi.org\/10.1002\/adma.202008065","journal-title":"Adv Mater"},{"key":"17_CR71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature17393","volume":"532","author":"L Jiang","year":"2016","unstructured":"Jiang L, Shestov AA, Swain P et al (2016) Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532:255\u2013258. https:\/\/doi.org\/10.1038\/nature17393","journal-title":"Nature"},{"key":"17_CR72","doi-asserted-by":"publisher","first-page":"490399","DOI":"10.3389\/FONC.2019.01196\/BIBTEX","volume":"9","author":"Q Jiang","year":"2019","unstructured":"Jiang Q, Zhang C, Wang H et al (2019) Mitochondria-targeting immunogenic cell death inducer improves the adoptive T-cell therapy against solid tumor. Front Oncol 9:490399. https:\/\/doi.org\/10.3389\/FONC.2019.01196\/BIBTEX","journal-title":"Front Oncol"},{"key":"17_CR73","doi-asserted-by":"publisher","first-page":"10327","DOI":"10.1021\/ACSNANO.2C00192","volume":"16","author":"J Jin","year":"2022","unstructured":"Jin J, Yuan P, Yu W et al (2022a) Mitochondria-targeting polymer micelle of dichloroacetate induced pyroptosis to enhance osteosarcoma immunotherapy. ACS Nano 16:10327\u201310340. https:\/\/doi.org\/10.1021\/ACSNANO.2C00192","journal-title":"ACS Nano"},{"key":"17_CR74","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","volume":"15","author":"P Jin","year":"2022","unstructured":"Jin P, Jiang J, Zhou L et al (2022b) Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol 15:97. https:\/\/doi.org\/10.1186\/s13045-022-01313-4","journal-title":"J Hematol Oncol"},{"key":"17_CR75","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"E-K Jo","year":"2016","unstructured":"Jo E-K, Kim JK, Shin D-M, Sasakawa C (2016) Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol 13:148\u2013159. https:\/\/doi.org\/10.1038\/cmi.2015.95","journal-title":"Cell Mol Immunol"},{"key":"17_CR76","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Walker CL, Rathmell WK (2021) Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol 17:245\u2013261","journal-title":"Nat Rev Nephrol"},{"key":"17_CR77","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","volume":"12","author":"SM Kaech","year":"2012","unstructured":"Kaech SM, Cui W (2012) Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol 12:749\u2013761. https:\/\/doi.org\/10.1038\/nri3307","journal-title":"Nat Rev Immunol"},{"key":"17_CR78","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S1470-2045(19)30626-6","volume":"20","author":"K Kato","year":"2019","unstructured":"Kato K, Cho BC, Takahashi M et al (2019) Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 20:1506\u20131517. https:\/\/doi.org\/10.1016\/S1470-2045(19)30626-6","journal-title":"Lancet Oncol"},{"key":"17_CR79","doi-asserted-by":"publisher","first-page":"1114582","DOI":"10.3389\/FIMMU.2023.1114582","volume":"14","author":"CK Keerthana","year":"2023","unstructured":"Keerthana CK, Rayginia TP, Shifana SC et al (2023) The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Front Immunol 14:1114582. https:\/\/doi.org\/10.3389\/FIMMU.2023.1114582","journal-title":"Front Immunol"},{"key":"17_CR80","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/CANCERS15123225\/S1","volume":"15","author":"SH Kim","year":"2023","unstructured":"Kim SH, Kim MJ, Lim M et al (2023) Enhancement of the anticancer ability of natural killer cells through allogeneic mitochondrial transfer. Cancers (Basel) 15:3225. https:\/\/doi.org\/10.3390\/CANCERS15123225\/S1","journal-title":"Cancers (Basel)"},{"key":"17_CR81","doi-asserted-by":"crossref","unstructured":"Klein K, He K, Younes AI et al (2020) Role of mitochondria in cancer immune evasion and potential therapeutic approaches. Front Immunol 11","DOI":"10.3389\/fimmu.2020.573326"},{"key":"17_CR82","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1200\/JCO.20.01888","volume":"38","author":"T Kojima","year":"2020","unstructured":"Kojima T, Shah MA, Muro K et al (2020) Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer. J Clin Oncol 38:4138\u20134148. https:\/\/doi.org\/10.1200\/JCO.20.01888","journal-title":"J Clin Oncol"},{"key":"17_CR83","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer 11:325\u2013337. https:\/\/doi.org\/10.1038\/nrc3038","journal-title":"Nat Rev Cancer"},{"key":"17_CR84","doi-asserted-by":"publisher","unstructured":"Kouidhi S, Ben Ayed F, Benammar Elgaaied A (2018) Targeting tumor metabolism: a new challenge to improve immunotherapy. Front Immunol 9. https:\/\/doi.org\/10.3389\/fimmu.2018.00353","DOI":"10.3389\/fimmu.2018.00353"},{"key":"17_CR85","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41589-018-0217-y","volume":"15","author":"RA Kulkarni","year":"2019","unstructured":"Kulkarni RA, Bak DW, Wei D et al (2019) A chemoproteomic portrait of the oncometabolite fumarate. Nat Chem Biol 15:391\u2013400. https:\/\/doi.org\/10.1038\/s41589-018-0217-y","journal-title":"Nat Chem Biol"},{"key":"17_CR86","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/J.CANLET.2020.01.019","volume":"474","author":"CL Kuo","year":"2020","unstructured":"Kuo CL, Chou HY, Chiu YC et al (2020) Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis. Cancer Lett\u2009474:138\u2013150.\u2009https:\/\/doi.org\/10.1016\/J.CANLET.2020.01.019","journal-title":"Cancer Lett"},{"key":"17_CR87","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"C-L Kuo","year":"2022","unstructured":"Kuo C-L, Ponneri Babuharisankar A, Lin Y-C et al (2022) Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend. J Biomed Sci 29:74. https:\/\/doi.org\/10.1186\/s12929-022-00859-2","journal-title":"J Biomed Sci"},{"key":"17_CR88","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone RD, Zhao L, Englert JM et al (2019) Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science (1979) 366:1013\u20131021.\u2009https:\/\/doi.org\/10.1126\/science.aav2588","journal-title":"Science (1979)"},{"key":"17_CR89","doi-asserted-by":"crossref","unstructured":"Li Y, Zhu B (2018) Editorial: metabolism of cancer cells and immune cells in the tumor microenvironment. Front Immunol 9:1\u20132","DOI":"10.3389\/fimmu.2018.03080"},{"key":"17_CR90","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells?. Trends Biochem Sci 41:211\u2013218. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001","journal-title":"Trends Biochem Sci"},{"key":"17_CR91","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1111\/febs.15561","volume":"288","author":"I Liparulo","year":"2021","unstructured":"Liparulo I, Bergamini C, Bortolus M et al (2021) Coenzyme Q biosynthesis inhibition induces HIF-1\u03b1 stabilization and metabolic switch toward glycolysis. FEBS J 288:1956\u20131974. https:\/\/doi.org\/10.1111\/febs.15561","journal-title":"FEBS J"},{"key":"17_CR92","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41556-024-01419-6","volume":"26","author":"H Liu","year":"2024","unstructured":"Liu H, Zhen C, Xie J et al (2024) TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA. Nat Cell Biol 26:878\u2013891. https:\/\/doi.org\/10.1038\/s41556-024-01419-6","journal-title":"Nat Cell Biol"},{"key":"17_CR93","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/ijc.30074","volume":"139","author":"S Liu","year":"2016","unstructured":"Liu S, Feng M, Guan W (2016) Mitochondrial DNA sensing by STING signaling participates in inflammation, cancer and beyond. Int J Cancer 139:736\u2013741. https:\/\/doi.org\/10.1002\/ijc.30074","journal-title":"Int J Cancer"},{"key":"17_CR94","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm.3931","volume":"21","author":"X Liu","year":"2015","unstructured":"Liu X, Pu Y, Cron K et al (2015) CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med 21:1209\u20131215. https:\/\/doi.org\/10.1038\/nm.3931","journal-title":"Nat Med"},{"key":"17_CR95","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/J.IMMUNI.2020.04.011\/ASSET\/6DAAFBE1-EA49-4FD1-AC70-78946D3E5E87\/MAIN.ASSETS\/GR2.JPG","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN (2020) The CD47-SIRP\u03b1immune checkpoint. Immunity 52:742\u2013752. https:\/\/doi.org\/10.1016\/J.IMMUNI.2020.04.011\/ASSET\/6DAAFBE1-EA49-4FD1-AC70-78946D3E5E87\/MAIN.ASSETS\/GR2.JPG","journal-title":"Immunity"},{"key":"17_CR96","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cmet.2018.08.021","volume":"28","author":"SR Lord","year":"2018","unstructured":"Lord SR, Cheng W-C, Liu D et al (2018) Integrated pharmacodynamic analysis identifies two metabolic adaption pathways to metformin in breast cancer. Cell Metab 28:679\u2013688.e4. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.021","journal-title":"Cell Metab"},{"key":"17_CR97","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/J.CHEMBIOL.2021.08.001\/ATTACHMENT\/3B4B14BC-E5B3-477E-A668-C2DEA6CA0C35\/MMC3.PDF","volume":"29","author":"M Malinee","year":"2022","unstructured":"Malinee M, Pandian GN, Sugiyama H (2022) Targeted epigenetic induction of mitochondrial biogenesis enhances antitumor immunity in mouse model. Cell Chem Biol 29:463\u2013475.e6. https:\/\/doi.org\/10.1016\/J.CHEMBIOL.2021.08.001\/ATTACHMENT\/3B4B14BC-E5B3-477E-A668-C2DEA6CA0C35\/MMC3.PDF","journal-title":"Cell Chem Biol"},{"key":"17_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS (2020) Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun 11: 102. https:\/\/doi.org\/10.1038\/s41467-019-13668-3","journal-title":"Nat Commun"},{"key":"17_CR99","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nri.2017.66","volume":"17","author":"MM Mehta","year":"2017","unstructured":"Mehta MM, Weinberg SE, Chandel NS (2017) Mitochondrial control of immunity: beyond ATP. Nat Rev Immunol 17:608\u2013620. https:\/\/doi.org\/10.1038\/nri.2017.66","journal-title":"Nat Rev Immunol"},{"key":"17_CR100","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10602","volume":"481","author":"CM Metallo","year":"2012","unstructured":"Metallo CM, Gameiro PA, Bell EL et al (2012) Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481:380\u2013384. https:\/\/doi.org\/10.1038\/nature10602","journal-title":"Nature"},{"key":"17_CR101","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina JR, Sun Y, Protopopova M et al (2018) An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med 24:1036\u20131046. https:\/\/doi.org\/10.1038\/s41591-018-0052-4","journal-title":"Nat Med"},{"key":"17_CR102","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature10642","volume":"481","author":"AR Mullen","year":"2011","unstructured":"Mullen AR, Wheaton WW, Jin ES et al (2011) Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481:385\u2013388. https:\/\/doi.org\/10.1038\/nature10642","journal-title":"Nature"},{"key":"17_CR103","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/s0022-2836(75)80187-2","volume":"99","author":"WI Murphy","year":"1975","unstructured":"Murphy WI, Attardi B, Tu C, Attardi G (1975) Evidence for complete symmetrical transcription in vivo of mitochondrial DNA in HeLa cells. J Mol Biol 99:809\u2013814. https:\/\/doi.org\/10.1016\/s0022-2836(75)80187-2","journal-title":"J Mol Biol"},{"key":"17_CR104","doi-asserted-by":"publisher","unstructured":"Najjar YG, Menk A V, Sander C et al (2019) Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma. JCI Insight 4. https:\/\/doi.org\/10.1172\/jci.insight.124989","DOI":"10.1172\/jci.insight.124989"},{"key":"17_CR105","unstructured":"Nelson DL, Lehninger AL, Cox MM (2009) Lehninger principles of biochemistry. W.H. Freeman 489\u2013559; 601\u2013629; 690\u2013750"},{"key":"17_CR106","unstructured":"Nicholls DG, Ferguson SJ (2013) Bioenergetics. Elsevier, Academic Press"},{"key":"17_CR107","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.devcel.2021.12.020","volume":"57","author":"R Ojha","year":"2022","unstructured":"Ojha R, Tantray I, Rimal S et al (2022) Regulation of reverse electron transfer at mitochondrial complex I by unconventional Notch action in cancer stem cells. Dev Cell 57:260\u2013276.e9. https:\/\/doi.org\/10.1016\/j.devcel.2021.12.020","journal-title":"Dev Cell"},{"key":"17_CR108","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1172\/JCI87800","volume":"127","author":"A Okazaki","year":"2017","unstructured":"Okazaki A, Gameiro PA, Christodoulou D et al (2017) Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers. J Clin Invest 127:1631\u20131645. https:\/\/doi.org\/10.1172\/JCI87800","journal-title":"J Clin Invest"},{"key":"17_CR109","doi-asserted-by":"publisher","unstructured":"O\u2019Sullivan D, Stanczak MA, Villa M et al (2021) Fever supports CD8+ effector T cell responses by promoting mitochondrial translation. Proc Natl Acad Sci USA 118. https:\/\/doi.org\/10.1073\/pnas.2023752118","DOI":"10.1073\/pnas.2023752118"},{"key":"17_CR110","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.cell.2022.03.030","volume":"185","author":"R Pan","year":"2022","unstructured":"Pan R, Ryan J, Pan D et al (2022) Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis. Cell 185:1521\u20131538.e18. https:\/\/doi.org\/10.1016\/j.cell.2022.03.030","journal-title":"Cell"},{"key":"17_CR111","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/ANNUREV-CANCERBIO-061421-042605\/CITE\/REFWORKS","volume":"7","author":"CH Patel","year":"2023","unstructured":"Patel CH, Powell JD (2023) Immune cell metabolism and immuno-oncology. Annu Rev Cancer Biol 7:93\u2013110. https:\/\/doi.org\/10.1146\/ANNUREV-CANCERBIO-061421-042605\/CITE\/REFWORKS","journal-title":"Annu Rev Cancer Biol"},{"key":"17_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","volume":"6","author":"N Patsoukis","year":"2015","unstructured":"Patsoukis N, Bardhan K, Chatterjee P et al (2015) PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun 6: 6692. https:\/\/doi.org\/10.1038\/ncomms7692","journal-title":"Nat Commun"},{"key":"17_CR113","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"},{"key":"17_CR114","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","volume":"38","author":"EL Pearce","year":"2013","unstructured":"Pearce EL, Pearce EJ (2013) Metabolic pathways in immune cell activation and quiescence. Immunity 38:633\u2013643. https:\/\/doi.org\/10.1016\/j.immuni.2013.04.005","journal-title":"Immunity"},{"key":"17_CR115","doi-asserted-by":"publisher","first-page":"165761","DOI":"10.1016\/j.bbadis.2020.165761","volume":"1866","author":"P P\u00e9rez-Trevi\u00f1o","year":"2020","unstructured":"P\u00e9rez-Trevi\u00f1o P, Vel\u00e1squez M, Garc\u00eda N (2020) Mechanisms of mitochondrial DNA escape and its relationship with different metabolic diseases. Biochim Biophys Acta 1866:165761. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165761","journal-title":"Biochim Biophys Acta"},{"key":"17_CR116","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1126\/science.1058079","volume":"292","author":"T Pfeiffer","year":"2001","unstructured":"Pfeiffer T, Schuster S, Bonhoeffer S (2001) Cooperation and competition in the evolution of ATP-producing pathways. Science 292:504\u2013507. https:\/\/doi.org\/10.1126\/science.1058079","journal-title":"Science"},{"key":"17_CR117","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.4049\/jimmunol.1500281","volume":"195","author":"S Pierini","year":"2015","unstructured":"Pierini S, Fang C, Rafail S et al (2015) A tumor mitochondria vaccine protects against experimental renal cell carcinoma. J Immunol 195:4020\u20134027. https:\/\/doi.org\/10.4049\/jimmunol.1500281","journal-title":"J Immunol"},{"key":"17_CR118","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.trsl.2018.07.013","volume":"202","author":"S Pustylnikov","year":"2018","unstructured":"Pustylnikov S, Costabile F, Beghi S, Facciabene A (2018) Targeting mitochondria in cancer: current concepts and immunotherapy approaches. Transl Res 202:35\u201351. https:\/\/doi.org\/10.1016\/j.trsl.2018.07.013","journal-title":"Transl Res"},{"key":"17_CR119","doi-asserted-by":"publisher","unstructured":"Qi H, Ning X, Yu C et al (2019) Succinylation-dependent mitochondrial translocation of PKM2 promotes cell survival in response to nutritional stress. Cell Death Dis 10. https:\/\/doi.org\/10.1038\/s41419-018-1271-9","DOI":"10.1038\/s41419-018-1271-9"},{"key":"17_CR120","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","volume":"81","author":"Y Qing","year":"2021","unstructured":"Qing Y, Dong L, Gao L et al (2021) R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m6A\/PFKP\/LDHB axis. Mol Cell 81:922\u2013939.e9. https:\/\/doi.org\/10.1016\/j.molcel.2020.12.026","journal-title":"Mol Cell"},{"key":"17_CR121","doi-asserted-by":"publisher","first-page":"27255","DOI":"10.1074\/jbc.M112.374629","volume":"287","author":"CL Quinlan","year":"2012","unstructured":"Quinlan CL, Orr AL, Perevoshchikova IV et al (2012) Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J Biol Chem 287:27255\u201327264. https:\/\/doi.org\/10.1074\/jbc.M112.374629","journal-title":"J Biol Chem"},{"key":"17_CR122","doi-asserted-by":"publisher","first-page":"14418","DOI":"10.1073\/pnas.0703126104","volume":"104","author":"A Quintana","year":"2007","unstructured":"Quintana A, Schwindling C, Wenning AS et al (2007) T cell activation requires mitochondrial translocation to the immunological synapse. Proc Natl Acad Sci USA 104:14418\u201314423. https:\/\/doi.org\/10.1073\/pnas.0703126104","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR123","doi-asserted-by":"publisher","unstructured":"Ramazi S, Zahiri J (2021) Posttranslational modifications in proteins: resources, tools and prediction methods. Database (Oxford) https:\/\/doi.org\/10.1093\/database\/baab012","DOI":"10.1093\/database\/baab012"},{"key":"17_CR124","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath S, Sharma R, Gupta R et al (2021) MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res 49:D1541\u2013D1547. https:\/\/doi.org\/10.1093\/nar\/gkaa1011","journal-title":"Nucleic Acids Res"},{"key":"17_CR125","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/S00125-013-2991-0\/FIGURES\/1","volume":"56","author":"G Rena","year":"2013","unstructured":"Rena G, Pearson ER, Sakamoto K (2013) Molecular mechanism of action of metformin: old or new insights?. Diabetologia 56:1898\u20131906. https:\/\/doi.org\/10.1007\/S00125-013-2991-0\/FIGURES\/1","journal-title":"Diabetologia"},{"key":"17_CR126","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1074\/jbc.RA118.003647","volume":"293","author":"EL Robb","year":"2018","unstructured":"Robb EL, Hall AR, Prime TA et al (2018) Control of mitochondrial superoxide production by reverse electron transport at complex I. J Biol Chem 293:9869\u20139879. https:\/\/doi.org\/10.1074\/jbc.RA118.003647","journal-title":"J Biol Chem"},{"key":"17_CR127","doi-asserted-by":"publisher","unstructured":"Rundqvist H, Veli\u00e7a P, Barbieri L et al (2020) Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. Elife 9. https:\/\/doi.org\/10.7554\/eLife.59996","DOI":"10.7554\/eLife.59996"},{"key":"17_CR128","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0925-4439(97)00035-5","volume":"1361","author":"P Rustin","year":"1997","unstructured":"Rustin P, Bourgeron T, Parfait B et al (1997) Inborn errors\u00a0of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim Biophys Acta 1361:185\u2013197. https:\/\/doi.org\/10.1016\/S0925-4439(97)00035-5","journal-title":"Biochim Biophys Acta"},{"key":"17_CR129","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","volume":"17","author":"T Saha","year":"2022","unstructured":"Saha T, Dash C, Jayabalan R et al (2022) Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat Nanotechnol 17:98\u2013106. https:\/\/doi.org\/10.1038\/s41565-021-01000-4","journal-title":"Nat Nanotechnol"},{"key":"17_CR130","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, Menk AV, Moreci RS et al (2016) The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45:374\u2013388. https:\/\/doi.org\/10.1016\/j.immuni.2016.07.009","journal-title":"Immunity"},{"key":"17_CR131","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","volume":"5","author":"NE Scharping","year":"2017","unstructured":"Scharping NE, Menk AV, Whetstone RD et al (2017) Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia. Cancer Immunol Res 5:9\u201316. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0103","journal-title":"Cancer Immunol Res"},{"key":"17_CR132","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fphys.2017.00428","volume":"8","author":"F Scial\u00f2","year":"2017","unstructured":"Scial\u00f2 F, Fern\u00e1ndez-Ayala DJ, Sanz A (2017) Role of mitochondrial reverse electron transport in ROS signaling: potential roles in health and disease. Front Physiol 8:428. https:\/\/doi.org\/10.3389\/fphys.2017.00428","journal-title":"Front Physiol"},{"key":"17_CR133","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak MA, Armour SM, MacKenzie ED et al (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-\u03b1 prolyl hydroxylase. Cancer Cell 7:77\u201385. https:\/\/doi.org\/10.1016\/j.ccr.2004.11.022","journal-title":"Cancer Cell"},{"key":"17_CR134","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1172\/JCI67230","volume":"123","author":"GL Semenza","year":"2013","unstructured":"Semenza GL (2013) HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J\u00a0Clin Invest 123:3664\u20133671. https:\/\/doi.org\/10.1172\/JCI67230","journal-title":"J Clin Invest"},{"key":"17_CR135","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza GL, Gregg LS (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148:399\u2013408. https:\/\/doi.org\/10.1016\/j.cell.2012.01.021","journal-title":"Cell"},{"key":"17_CR136","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","volume":"38","author":"LA Sena","year":"2013","unstructured":"Sena LA, Li S, Jairaman A et al (2013) Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38:225\u2013236. https:\/\/doi.org\/10.1016\/j.immuni.2012.10.020","journal-title":"Immunity"},{"key":"17_CR137","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mito.2012.11.001","volume":"13","author":"F Sj\u00f6vall","year":"2013","unstructured":"Sj\u00f6vall F, Ehinger JKH, Marelsson SE et al (2013) Mitochondrial respiration in human viable platelets\u2014Methodology and influence of gender, age and storage. Mitochondrion 13:7\u201314. https:\/\/doi.org\/10.1016\/j.mito.2012.11.001","journal-title":"Mitochondrion"},{"key":"17_CR138","doi-asserted-by":"publisher","first-page":"e002044","DOI":"10.1136\/jitc-2020-002044","volume":"9","author":"K Slattery","year":"2021","unstructured":"Slattery K, Woods E, Zaiatz-Bittencourt V et al (2021) TGF\u03b2 drives NK cell metabolic dysfunction in human metastatic breast cancer. J Immunother Cancer 9:e002044. https:\/\/doi.org\/10.1136\/jitc-2020-002044","journal-title":"J Immunother Cancer"},{"key":"17_CR139","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","volume":"172","author":"R Su","year":"2017","unstructured":"Su R, Dong L, Li C et al (2017) R-2HG exhibits anti-tumor activity by targeting FTO\/m 6 A\/MYC\/CEBPA signaling. Cell 172:90\u201391.e23 https:\/\/doi.org\/10.1016\/j.cell.2017.11.031","journal-title":"Cell"},{"key":"17_CR140","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1172\/JCI69589","volume":"123","author":"M Sukumar","year":"2013","unstructured":"Sukumar M, Liu J, Ji Y et al (2013) Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J Clin Invest 123:4479\u20134488. https:\/\/doi.org\/10.1172\/JCI69589","journal-title":"J Clin Invest"},{"key":"17_CR141","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","volume":"122","author":"L Vettore","year":"2020","unstructured":"Vettore L, Westbrook RL, Tennant DA (2020) New aspects of amino acid metabolism in cancer. Br J Cancer 122:150\u2013156. https:\/\/doi.org\/10.1038\/s41416-019-0620-5","journal-title":"Br J Cancer"},{"key":"17_CR142","doi-asserted-by":"crossref","unstructured":"Viola A, Munari F, S\u00e1nchez-Rodr\u00edguez R et al (2019) The metabolic signature of macrophage responses. Front Immunol 10","DOI":"10.3389\/fimmu.2019.01462"},{"key":"17_CR143","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2012","unstructured":"Viollet B, Guigas B, Sanz Garcia N et al (2012) Cellular and molecular mechanisms of metformin: an overview. Clin Sci 122:253\u2013270. https:\/\/doi.org\/10.1042\/CS20110386","journal-title":"Clin Sci"},{"key":"17_CR144","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M et al (2008) Functions of natural killer cells. Nat Immunol 9:503\u2013510. https:\/\/doi.org\/10.1038\/ni1582","journal-title":"Nat Immunol"},{"key":"17_CR145","doi-asserted-by":"crossref","unstructured":"Wang Z, Guan D, Wang S et al (2020) Glycolysis and oxidative phosphorylation play critical roles in natural killer cell receptor-mediated natural killer cell functions. Front Immunol 11","DOI":"10.3389\/fimmu.2020.00202"},{"key":"17_CR146","doi-asserted-by":"publisher","unstructured":"Wangpaichitr M, Kandemir H, Li YY et al (2017) Relationship of metabolic alterations and PD-L1 expression in cisplatin resistant lung cancer. Cell Dev Biol 6. https:\/\/doi.org\/10.4172\/2168-9296.1000183","DOI":"10.4172\/2168-9296.1000183"},{"key":"17_CR147","first-page":"309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science (1979) 123:309\u2013314","journal-title":"Science (1979)"},{"key":"17_CR148","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519\u2013530","journal-title":"J Gen Physiol"},{"key":"17_CR149","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward PS, Patel J, Wise DR et al (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17:225\u2013234. https:\/\/doi.org\/10.1016\/j.ccr.2010.01.020","journal-title":"Cancer Cell"},{"key":"17_CR150","doi-asserted-by":"publisher","first-page":"e02242","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton WW, Weinberg SE, Hamanaka RB et al (2014) Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. eLife 3:e02242\u2013e02242. https:\/\/doi.org\/10.7554\/eLife.02242","journal-title":"eLife"},{"key":"17_CR151","doi-asserted-by":"publisher","first-page":"19611","DOI":"10.1073\/pnas.1117773108","volume":"108","author":"DR Wise","year":"2011","unstructured":"Wise DR, Ward PS, Shay JE et al (2011) Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci USA 108:19611\u201319616. https:\/\/doi.org\/10.1073\/pnas.1117773108","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR152","doi-asserted-by":"publisher","unstructured":"Wolf T, Jin W, Zoppi G et al (2020) Dynamics in protein translation sustaining T cell preparedness. Nat\u00a0Immunol https:\/\/doi.org\/10.1038\/s41590-020-0714-5","DOI":"10.1038\/s41590-020-0714-5"},{"key":"17_CR153","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.cmet.2020.10.025","volume":"32","author":"B Wu","year":"2020","unstructured":"Wu B, Qiu J, Zhao TV et al (2020) Succinyl-CoA ligase deficiency in pro-inflammatory and tissue-invasive T cells. Cell Metab 32:967\u2013980.e5. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.025","journal-title":"Cell Metab"},{"key":"17_CR154","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao M, Yang H, Xu W et al (2012) Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 26:1326\u20131338","journal-title":"Genes Dev"},{"key":"17_CR155","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00262-024-03748-9","volume":"73","author":"Q Xie","year":"2024","unstructured":"Xie Q, Zeng Y, Zhang X, Yu F (2024) The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma. Cancer Immunol Immunother 73:171. https:\/\/doi.org\/10.1007\/s00262-024-03748-9","journal-title":"Cancer Immunol Immunother"},{"key":"17_CR156","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.immuni.2017.07.016","volume":"47","author":"MM Xu","year":"2017","unstructured":"Xu MM, Pu Y, Han D et al (2017) Dendritic cells but not macrophages sense tumor mitochondrial DNA forcross-priming through signal regulatory protein \u03b1 signaling. Immunity 47:363\u2013373.e5. https:\/\/doi.org\/10.1016\/j.immuni.2017.07.016","journal-title":"Immunity"},{"key":"17_CR157","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu W, Yang H, Liu Y et al (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17\u201330","journal-title":"Cancer Cell"},{"key":"17_CR158","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/J.CMET.2022.02.009","volume":"34","author":"L Ye","year":"2022","unstructured":"Ye L, Park JJ, Peng L et al (2022) A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metab 34:595\u2013614.e14. https:\/\/doi.org\/10.1016\/J.CMET.2022.02.009","journal-title":"Cell Metab"},{"key":"17_CR159","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/2211-5463.13630","volume":"13","author":"Y Yu","year":"2023","unstructured":"Yu Y, Wu Y, Zhang Y et al (2023) Oxidative stress in the tumor microenvironment in gastric cancer and its potential role in immunotherapy. FEBS Open Bio 13:1238\u20131252. https:\/\/doi.org\/10.1002\/2211-5463.13630","journal-title":"FEBS Open Bio"},{"key":"17_CR160","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-023-05770-w","volume":"615","author":"V Zecchini","year":"2023","unstructured":"Zecchini V, Paupe V, Herranz-Montoya I et al (2023) Fumarate induces vesicular release of mtDNA to drive innate immunity. Nature 615:499\u2013506. https:\/\/doi.org\/10.1038\/s41586-023-05770-w","journal-title":"Nature"},{"key":"17_CR161","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.immuni.2016.01.007","volume":"44","author":"B Zhang","year":"2016","unstructured":"Zhang B, Liu S-Q, Li C et al (2016) MicroRNA-23a curbs necrosis during early T cell activation by enforcing intracellular reactive oxygen species equilibrium. Immunity 44:568\u2013581. https:\/\/doi.org\/10.1016\/j.immuni.2016.01.007","journal-title":"Immunity"},{"key":"17_CR162","doi-asserted-by":"crossref","unstructured":"Zhang W, Huang Q, Xiao W et al (2020) Advances inanti-tumor treatments targeting the CD47\/SIRP\u03b1 axis. Front Immunol 11","DOI":"10.3389\/fimmu.2020.00018"},{"key":"17_CR163","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","volume":"32","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Kurupati R, Liu L et al (2017) Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Cancer Cell 32:377\u2013391.e9. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.004","journal-title":"Cancer Cell"},{"key":"17_CR164","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nchembio.495","volume":"7","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Tan M, Xie Z et al (2011) Identification of lysine succinylation as a new post-translational modification. Nat Chem Biol 7:58\u201363. https:\/\/doi.org\/10.1038\/nchembio.495","journal-title":"Nat Chem Biol"},{"key":"17_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12943-017-0648-1","volume":"16","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Hu X, Liu Y et al (2017) ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer 16:1\u201312. https:\/\/doi.org\/10.1186\/S12943-017-0648-1","journal-title":"Mol Cancer"},{"key":"17_CR166","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","volume":"20","author":"X Zheng","year":"2019","unstructured":"Zheng X, Qian Y, Fu B et al (2019) Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance. Nat Immunol 20:1656\u20131667. https:\/\/doi.org\/10.1038\/s41590-019-0511-1","journal-title":"Nat Immunol"},{"key":"17_CR167","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469:221\u2013225. https:\/\/doi.org\/10.1038\/nature09663","journal-title":"Nature"}],"container-title":["Advances in Experimental Medicine and Biology","Cancer Metabolic Remodeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-12166-0_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:17:07Z","timestamp":1783768627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-12166-0_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032121653","9783032121660"],"references-count":167,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-12166-0_17","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"12 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}